Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

VistaGen Therapeutics, Inc

VistaGen Therapeutics is a biopharmaceutical company developing breakthrough drugs for disorders of the Central Nervous System (CNS) and diabetes.
Our lead drug candidate AV-101 targets two large CNS markets epilepsy and neuropathic pain. Our key R&D partnership applies our clinically predictive in vitro embryonic stem cell technologies to discover and develop a new generation of drug candidates for diabetes and other metabolic syndrome diseases.

We are developing an internal pipeline of products to provide late-stage product opportunities for large pharmaceutical companies by advancing new generation drug candidates through Phase 2 clinical trials and pursuing partnerships to complete Phase 3 development and commercialization. By combining internal and collaborative drug development programs, widely applicable core technologies, and multiple revenue-generating partnerships VistaGen provides both near and long-term investor opportunities.


Contact Details:
1450 Rollins Road
Burlingame
California
94010
United States of America
Tel:(650) 558-9500
Fax:(650) 558-9566
Email:webmaster@vistagen-inc.com
WWW:

www.vistagen-inc.com/




Loading...

BioNews Results for VistaGen Therapeutics, Inc:

Amicus Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report
PR inside:  Nov 16 2009 5:37AM Matching: therapeutics inc
Arana Therapeutics Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report
PR inside:  Nov 16 2009 5:14AM Matching: therapeutics inc
XTEN Data From Amunix and Versartis Featured in Nature Biotechnology as a Novel Platform for Increasing Serum Half-Life of Protein Therapeutics
Earthtimes.org:  Nov 15 2009 7:40PM Matching: therapeutics inc
BiomedReports: News and FDA Updates for PharmAthene (NYSE:PIP), Repros Therapeutics (Nasdaq:RPRX)
Quote.com Japan:  Nov 14 2009 10:27PM Matching: therapeutics inc
Maxygen, Inc. Commences Dutch Auction Tender Offer to Repurchase 6,557,377 Shares of Common Stock
KOTA Territory News:  Nov 14 2009 11:05PM Matching: therapeutics inc
Promote your company here: BioNewsCast - Press Release Distribution

View more VistaGen Therapeutics, Inc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 444 times since April 2007, the link to the organisation's website has been followed 78 times

Recent Search Terms used to find this page: vistagen therapeutics october 2009 | Vistagen Therapeutics Inc. | av 101 vistagen | vistagen revenue | vistagen therapeutics inc. | av-101 2009 VistaGen | .

Search for more companies in Burlingame

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for VistaGen Therapeutics, Inc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.